According to the research report, the global nutraceuticalingredients market size is expected to touch USD 330 Billion by 2030, from USD 176.84 Billion in 2021, growing with a significant CAGR of 7.18% from 2022 to 2030.
The nutraceutical ingredients market report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global nutraceutical ingredients market in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global nutraceutical ingredients market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global nutraceutical ingredients market during the
forecast period. It also includes a key indicator assessment that highlights
growth prospects of this market and estimates statistics related to growth of
the market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1162
| Report Highlights | Details |
| Market Size | USD 330 Billion by 2030 |
| Growth Rate | CAGR of 7.18% from 2022 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Type, Application, Health Benefits, Form, Region |
This study covers a detailed segmentation
of the global nutraceutical ingredients market, along with key information and
a competition outlook. The report mentions company profiles of players that are
currently dominating the global nutraceutical ingredients market, wherein
various developments, expansions, and winning strategies practiced and
implemented by leading players have been presented in detail.
Key Players
- Kraft Heinz Company
- GlaxoSmithKline
- Amway
- Abbott
- Kellogg’s
- Danone
- Cargill Inc.,
- Nestle
- Archer Daniels Midland
- DSM
- BASF
- PepsiCo
- General Mills
- Aker Biomarine
- Procter & Gamble
- Johnson & Johnson
Market Segmentation
- Probiotic
- Proteins and amino acids
- Phytochemical & plant extracts
- Fibers & specialty carbohydrates
- Omega 3 fatty acids
- Vitamins
- Prebiotic
- Carotenoids
- Minerals
- Others
By Application
- Food
- Beverages
- Personal care
- Animal nutrition
- Dietary supplements
By Health Benefits
- Cognitive health
- Gut health
- Heart health
- Bone health
- Immunity
- Nutrition
- Weigh management
- Others
By Form
- Dry
- liquid
By Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Research Methodology
The research methodology adopted by
analysts for compiling the global nutraceutical ingredients market report is
based on detailed primary as well as secondary research. With the help of
in-depth insights of the market-affiliated information that is obtained and
legitimated by market-admissible resources, analysts have offered riveting
observations and authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global nutraceutical ingredients market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Nutraceutical Ingredients Market, By Product
7.1. Nutraceutical Ingredients Market, by Product Type, 2020-2030
7.1.1. Probiotic
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Proteins and amino acids
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Phytochemical & plant extracts
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Fibers & specialty carbohydrates
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Omega 3 fatty acids
7.1.5.1. Market Revenue and Forecast (2017-2030)
7.1.6. Vitamins
7.1.6.1. Market Revenue and Forecast (2017-2030)
7.1.7. Prebiotic
7.1.7.1. Market Revenue and Forecast (2017-2030)
7.1.8. Carotenoids
7.1.8.1. Market Revenue and Forecast (2017-2030)
7.1.9. Minerals
7.1.9.1. Market Revenue and Forecast (2017-2030)
7.1.10. Others
7.1.10.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Nutraceutical Ingredients Market, By Application
8.1. Nutraceutical Ingredients Market, by Application, 2020-2030
8.1.1. Food
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Beverages
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Personal care
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Animal nutrition
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Dietary supplements
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Nutraceutical Ingredients Market, By Health Benefits
9.1. Nutraceutical Ingredients Market, by Health Benefits, 2020-2030
9.1.1. Cognitive health
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Gut health
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Heart health
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Bone health
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Immunity
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Nutrition
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Weigh management
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Others
9.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Nutraceutical Ingredients Market, By Form
10.1. Nutraceutical Ingredients Market, by Form, 2020-2030
10.1.1. Dry
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Liquid
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Nutraceutical Ingredients Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.1.4. Market Revenue and Forecast, by Form (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.1.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.1.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.7.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.8.4. Market Revenue and Forecast, by Form (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.7.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.8.4. Market Revenue and Forecast, by Form (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.7.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.8.4. Market Revenue and Forecast, by Form (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.5.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.5.6.4. Market Revenue and Forecast, by Form (2017-2030)
Chapter 12. Company Profiles
12.1. Kraft Heinz Company
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GlaxoSmithKline
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Amway
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Kellogg’s
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Danone
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cargill Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Nestle
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Archer Daniels Midland
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. DSM
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. BASF
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. General Mills
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Aker Biomarine
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Procter & Gamble
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. Johnson & Johnson
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
